157 related articles for article (PubMed ID: 32775868)
1. 2D-QSAR Modeling and Molecular Docking Studies on 1
Hajalsiddig TTH; Osman ABM; Saeed AEM
ACS Omega; 2020 Aug; 5(30):18662-18674. PubMed ID: 32775868
[TBL] [Abstract][Full Text] [Related]
2. 5D-QSAR studies of 1H-pyrazole derivatives as EGFR inhibitors.
Qin D; Zeng X; Zhao T; Cai B; Yang B; Tu G
J Mol Model; 2022 Nov; 28(12):379. PubMed ID: 36342554
[TBL] [Abstract][Full Text] [Related]
3. 2D and 3D-QSAR analysis of pyrazole-thiazolinone derivatives as EGFR kinase inhibitors by CoMFA and CoMSIA.
Pourbasheer E; Aalizadeh R; Shiri HM; Banaei A; Ganjali MR
Curr Comput Aided Drug Des; 2015; 11(4):292-303. PubMed ID: 26548551
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of a new series of pyrazole derivatives as a potent epidermal growth factor receptor inhibitory activity: QSAR modeling using quantum-chemical descriptors.
Said RB; Hanachi R; Rahali S; Alkhalifah MAM; Alresheedi F; Tangour B; Hochlaf M
J Comput Chem; 2021 Dec; 42(32):2306-2320. PubMed ID: 34609748
[TBL] [Abstract][Full Text] [Related]
5. QSAR Modeling of COX -2 Inhibitory Activity of Some Dihydropyridine and Hydroquinoline Derivatives Using Multiple Linear Regression (MLR) Method.
Akbari S; Zebardast T; Zarghi A; Hajimahdi Z
Iran J Pharm Res; 2017; 16(2):525-532. PubMed ID: 28979307
[TBL] [Abstract][Full Text] [Related]
6. A study on quantitative structure-activity relationship and molecular docking of metalloproteinase inhibitors based on L-tyrosine scaffold.
Abbasi M; Ramezani F; Elyasi M; Sadeghi-Aliabadi H; Amanlou M
Daru; 2015 Apr; 23(1):29. PubMed ID: 25925871
[TBL] [Abstract][Full Text] [Related]
7. 2D QSAR and Virtual Screening based on Pyridopyrimidine Analogs of Epidermal Growth Factor Receptor Tyrosine Kinase.
Sugunakala S; Selvaraj S
Curr Comput Aided Drug Des; 2016; 12(3):229-240. PubMed ID: 27264509
[TBL] [Abstract][Full Text] [Related]
8. Comparative chemometric modeling of cytochrome 3A4 inhibitory activity of structurally diverse compounds using stepwise MLR, FA-MLR, PLS, GFA, G/PLS and ANN techniques.
Roy K; Pratim Roy P
Eur J Med Chem; 2009 Jul; 44(7):2913-22. PubMed ID: 19128860
[TBL] [Abstract][Full Text] [Related]
9. Design and prediction of novel pyrazole derivatives as potential anti-cancer compounds based on 2D-2D-QSAR study against PC-3, B16F10, K562, MDA-MB-231, A2780, ACHN and NUGC cancer cell lines.
Bennani FE; Doudach L; Karrouchi K; El Rhayam Y; Rudd CE; Ansar M; El Abbes Faouzi M
Heliyon; 2022 Aug; 8(8):e10003. PubMed ID: 35965973
[TBL] [Abstract][Full Text] [Related]
10. 2D-QSAR and 3D-QSAR Analyses for EGFR Inhibitors.
Zhao M; Wang L; Zheng L; Zhang M; Qiu C; Zhang Y; Du D; Niu B
Biomed Res Int; 2017; 2017():4649191. PubMed ID: 28630865
[TBL] [Abstract][Full Text] [Related]
11. Predictive QSAR modeling of CCR5 antagonist piperidine derivatives using chemometric tools.
Roy K; Mandal AS
J Enzyme Inhib Med Chem; 2009 Feb; 24(1):205-23. PubMed ID: 18608745
[TBL] [Abstract][Full Text] [Related]
12. Application of GA-MLR for QSAR Modeling of the Arylthioindole Class of Tubulin Polymerization Inhibitors as Anticancer Agents.
Ahmadi S; Habibpour E
Anticancer Agents Med Chem; 2017; 17(4):552-565. PubMed ID: 27528182
[TBL] [Abstract][Full Text] [Related]
13. Prediction of new Hsp90 inhibitors based on 3,4-isoxazolediamide scaffold using QSAR study, molecular docking and molecular dynamic simulation.
Abbasi M; Sadeghi-Aliabadi H; Amanlou M
Daru; 2017 Jun; 25(1):17. PubMed ID: 28666484
[TBL] [Abstract][Full Text] [Related]
14. Genetic Algorithm and Self-Organizing Maps for QSPR Study of Some N-aryl Derivatives as Butyrylcholinesterase Inhibitors.
Ahmadi S; Ganji S
Curr Drug Discov Technol; 2016; 13(4):232-253. PubMed ID: 27457492
[TBL] [Abstract][Full Text] [Related]
15. Development of linear and nonlinear predictive QSAR models and their external validation using molecular similarity principle for anti-HIV indolyl aryl sulfones.
Roy K; Mandal AS
J Enzyme Inhib Med Chem; 2008 Dec; 23(6):980-95. PubMed ID: 18608761
[TBL] [Abstract][Full Text] [Related]
16. Docking and QSAR Studies of 1,4-Dihydropyridine Derivatives as Anti- Cancer Agent.
Mollazadeh S; Shamsara J; Iman M; Hadizadeh F
Recent Pat Anticancer Drug Discov; 2017; 12(2):174-185. PubMed ID: 28137213
[TBL] [Abstract][Full Text] [Related]
17. In silico evaluation, molecular docking and QSAR analysis of quinazoline-based EGFR-T790M inhibitors.
Asadollahi-Baboli M
Mol Divers; 2016 Aug; 20(3):729-39. PubMed ID: 27209475
[TBL] [Abstract][Full Text] [Related]
18. Insights into the EGFR SAR of N-phenylquinazolin-4-amine-derivatives using quantum mechanical pairwise-interaction energies.
Simeon S; Jongkon N; Chotpatiwetchkul W; Gleeson MP
J Comput Aided Mol Des; 2019 Aug; 33(8):745-757. PubMed ID: 31494804
[TBL] [Abstract][Full Text] [Related]
19. Quantitative Structure-Activity Relationship Study of Camptothecin Derivatives as Anticancer Drugs Using Molecular Descriptors.
Ahmadinejad N; Shafiei F
Comb Chem High Throughput Screen; 2019; 22(6):387-399. PubMed ID: 31284856
[TBL] [Abstract][Full Text] [Related]
20. Prediction of Activities of BRAF (V600E) Inhibitors by SW-MLR and GA-MLR Methods.
Pargolghasemi P; Hoseininezhad-Namin MS; Jadid AP
Curr Comput Aided Drug Des; 2017; 13(3):249-261. PubMed ID: 28260510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
